nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Cranial nerve paralysis—Methotrexate—ankylosing spondylitis	0.0444	0.0444	CcSEcCtD
Nalidixic Acid—Papilloedema—Prednisolone—ankylosing spondylitis	0.0265	0.0265	CcSEcCtD
Nalidixic Acid—Papilloedema—Triamcinolone—ankylosing spondylitis	0.0244	0.0244	CcSEcCtD
Nalidixic Acid—Papilloedema—Methylprednisolone—ankylosing spondylitis	0.0243	0.0243	CcSEcCtD
Nalidixic Acid—Papilloedema—Dexamethasone—ankylosing spondylitis	0.0221	0.0221	CcSEcCtD
Nalidixic Acid—Papilloedema—Betamethasone—ankylosing spondylitis	0.0221	0.0221	CcSEcCtD
Nalidixic Acid—Intracranial pressure increased—Prednisolone—ankylosing spondylitis	0.0202	0.0202	CcSEcCtD
Nalidixic Acid—Metabolic acidosis—Methylprednisolone—ankylosing spondylitis	0.0196	0.0196	CcSEcCtD
Nalidixic Acid—Papilloedema—Prednisone—ankylosing spondylitis	0.0193	0.0193	CcSEcCtD
Nalidixic Acid—Intracranial pressure increased—Triamcinolone—ankylosing spondylitis	0.0186	0.0186	CcSEcCtD
Nalidixic Acid—Intracranial pressure increased—Methylprednisolone—ankylosing spondylitis	0.0185	0.0185	CcSEcCtD
Nalidixic Acid—Epilepsy—Dexamethasone—ankylosing spondylitis	0.0185	0.0185	CcSEcCtD
Nalidixic Acid—Epilepsy—Betamethasone—ankylosing spondylitis	0.0185	0.0185	CcSEcCtD
Nalidixic Acid—Trauma—Prednisolone—ankylosing spondylitis	0.0177	0.0177	CcSEcCtD
Nalidixic Acid—Intracranial pressure increased—Dexamethasone—ankylosing spondylitis	0.0168	0.0168	CcSEcCtD
Nalidixic Acid—Intracranial pressure increased—Betamethasone—ankylosing spondylitis	0.0168	0.0168	CcSEcCtD
Nalidixic Acid—Trauma—Triamcinolone—ankylosing spondylitis	0.0163	0.0163	CcSEcCtD
Nalidixic Acid—Trauma—Methylprednisolone—ankylosing spondylitis	0.0162	0.0162	CcSEcCtD
Nalidixic Acid—Epilepsy—Prednisone—ankylosing spondylitis	0.0161	0.0161	CcSEcCtD
Nalidixic Acid—Trauma—Dexamethasone—ankylosing spondylitis	0.0148	0.0148	CcSEcCtD
Nalidixic Acid—Trauma—Betamethasone—ankylosing spondylitis	0.0148	0.0148	CcSEcCtD
Nalidixic Acid—Intracranial pressure increased—Prednisone—ankylosing spondylitis	0.0147	0.0147	CcSEcCtD
Nalidixic Acid—Optic neuritis—Prednisolone—ankylosing spondylitis	0.0137	0.0137	CcSEcCtD
Nalidixic Acid—Trauma—Prednisone—ankylosing spondylitis	0.0129	0.0129	CcSEcCtD
Nalidixic Acid—Optic neuritis—Triamcinolone—ankylosing spondylitis	0.0126	0.0126	CcSEcCtD
Nalidixic Acid—Optic neuritis—Methylprednisolone—ankylosing spondylitis	0.0126	0.0126	CcSEcCtD
Nalidixic Acid—Blister—Prednisolone—ankylosing spondylitis	0.0117	0.0117	CcSEcCtD
Nalidixic Acid—Optic neuritis—Dexamethasone—ankylosing spondylitis	0.0114	0.0114	CcSEcCtD
Nalidixic Acid—Optic neuritis—Betamethasone—ankylosing spondylitis	0.0114	0.0114	CcSEcCtD
Nalidixic Acid—Blister—Triamcinolone—ankylosing spondylitis	0.0108	0.0108	CcSEcCtD
Nalidixic Acid—Optic neuritis—Prednisone—ankylosing spondylitis	0.00995	0.00995	CcSEcCtD
Nalidixic Acid—Blister—Dexamethasone—ankylosing spondylitis	0.00975	0.00975	CcSEcCtD
Nalidixic Acid—Blister—Betamethasone—ankylosing spondylitis	0.00975	0.00975	CcSEcCtD
Nalidixic Acid—Injury—Prednisolone—ankylosing spondylitis	0.00665	0.00665	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Prednisolone—ankylosing spondylitis	0.0064	0.0064	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.00632	0.00632	CcSEcCtD
Nalidixic Acid—Injury—Triamcinolone—ankylosing spondylitis	0.00612	0.00612	CcSEcCtD
Nalidixic Acid—Injury—Methylprednisolone—ankylosing spondylitis	0.00611	0.00611	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Triamcinolone—ankylosing spondylitis	0.00589	0.00589	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.00581	0.00581	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.0058	0.0058	CcSEcCtD
Nalidixic Acid—Injury—Dexamethasone—ankylosing spondylitis	0.00555	0.00555	CcSEcCtD
Nalidixic Acid—Injury—Betamethasone—ankylosing spondylitis	0.00555	0.00555	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00548	0.00548	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Dexamethasone—ankylosing spondylitis	0.00534	0.00534	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Betamethasone—ankylosing spondylitis	0.00534	0.00534	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.00527	0.00527	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.00527	0.00527	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Nalidixic Acid—Injury—Prednisone—ankylosing spondylitis	0.00484	0.00484	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.00462	0.00462	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Prednisone—ankylosing spondylitis	0.00434	0.00434	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.00425	0.00425	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.00424	0.00424	CcSEcCtD
Nalidixic Acid—Visual impairment—Prednisolone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Nalidixic Acid—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Nalidixic Acid—Erythema—Prednisolone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Nalidixic Acid—Visual impairment—Dexamethasone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Nalidixic Acid—Visual impairment—Betamethasone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Nalidixic Acid—Erythema—Triamcinolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Nalidixic Acid—Erythema—Methylprednisolone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Nalidixic Acid—Angioedema—Prednisolone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Nalidixic Acid—Vertigo—Prednisolone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Nalidixic Acid—Convulsion—Prednisolone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Nalidixic Acid—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Nalidixic Acid—Angioedema—Triamcinolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Nalidixic Acid—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Nalidixic Acid—Erythema—Dexamethasone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Nalidixic Acid—Erythema—Betamethasone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Nalidixic Acid—Vertigo—Triamcinolone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Nalidixic Acid—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Nalidixic Acid—Convulsion—Triamcinolone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Nalidixic Acid—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Nalidixic Acid—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Nalidixic Acid—Drowsiness—Methotrexate—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Nalidixic Acid—Angioedema—Betamethasone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Nalidixic Acid—Angioedema—Dexamethasone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Nalidixic Acid—Vertigo—Dexamethasone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Nalidixic Acid—Vertigo—Betamethasone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Nalidixic Acid—Paraesthesia—Prednisolone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Nalidixic Acid—Erythema—Prednisone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Nalidixic Acid—Convulsion—Dexamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Nalidixic Acid—Convulsion—Betamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Nalidixic Acid—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Nalidixic Acid—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Nalidixic Acid—Visual impairment—Methotrexate—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Nalidixic Acid—Angioedema—Prednisone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Nalidixic Acid—Vertigo—Prednisone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Nalidixic Acid—Urticaria—Prednisolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Nalidixic Acid—Convulsion—Prednisone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Nalidixic Acid—Arthralgia—Prednisone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Nalidixic Acid—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Nalidixic Acid—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Nalidixic Acid—Erythema—Methotrexate—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Nalidixic Acid—Urticaria—Triamcinolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Nalidixic Acid—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Nalidixic Acid—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Nalidixic Acid—Vertigo—Methotrexate—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Nalidixic Acid—Leukopenia—Methotrexate—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Nalidixic Acid—Urticaria—Dexamethasone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Nalidixic Acid—Urticaria—Betamethasone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Nalidixic Acid—Dizziness—Prednisolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Nalidixic Acid—Asthenia—Triamcinolone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Nalidixic Acid—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Nalidixic Acid—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Nalidixic Acid—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Nalidixic Acid—Paraesthesia—Prednisone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Nalidixic Acid—Pruritus—Triamcinolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Nalidixic Acid—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Nalidixic Acid—Convulsion—Methotrexate—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Nalidixic Acid—Arthralgia—Methotrexate—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Nalidixic Acid—Rash—Prednisolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Nalidixic Acid—Dermatitis—Prednisolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Nalidixic Acid—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Nalidixic Acid—Headache—Prednisolone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Nalidixic Acid—Dizziness—Triamcinolone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Nalidixic Acid—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Nalidixic Acid—Asthenia—Dexamethasone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Nalidixic Acid—Asthenia—Betamethasone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Nalidixic Acid—Nausea—Prednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Nalidixic Acid—Pruritus—Dexamethasone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Nalidixic Acid—Pruritus—Betamethasone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Nalidixic Acid—Vomiting—Triamcinolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Nalidixic Acid—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Nalidixic Acid—Rash—Triamcinolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Nalidixic Acid—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Nalidixic Acid—Rash—Methylprednisolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Nalidixic Acid—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Nalidixic Acid—Urticaria—Prednisone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Nalidixic Acid—Headache—Triamcinolone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Nalidixic Acid—Headache—Methylprednisolone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Nalidixic Acid—Abdominal pain—Prednisone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Nalidixic Acid—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Nalidixic Acid—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Nalidixic Acid—Dizziness—Dexamethasone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Nalidixic Acid—Dizziness—Betamethasone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Nalidixic Acid—Nausea—Triamcinolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Nalidixic Acid—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Nalidixic Acid—Nausea—Methylprednisolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Nalidixic Acid—Somnolence—Methotrexate—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Nalidixic Acid—Vomiting—Betamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Nalidixic Acid—Vomiting—Dexamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Nalidixic Acid—Rash—Dexamethasone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Nalidixic Acid—Rash—Betamethasone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Nalidixic Acid—Dermatitis—Betamethasone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Nalidixic Acid—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Nalidixic Acid—Headache—Dexamethasone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Nalidixic Acid—Headache—Betamethasone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Nalidixic Acid—Asthenia—Prednisone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Nalidixic Acid—Pruritus—Prednisone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Nalidixic Acid—Diarrhoea—Prednisone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Nalidixic Acid—Nausea—Betamethasone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Nalidixic Acid—Nausea—Dexamethasone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Nalidixic Acid—Urticaria—Methotrexate—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Nalidixic Acid—Dizziness—Prednisone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Nalidixic Acid—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Nalidixic Acid—Vomiting—Prednisone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Nalidixic Acid—Rash—Prednisone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Nalidixic Acid—Dermatitis—Prednisone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Nalidixic Acid—Headache—Prednisone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Nalidixic Acid—Asthenia—Methotrexate—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Nalidixic Acid—Nausea—Prednisone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Nalidixic Acid—Pruritus—Methotrexate—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Nalidixic Acid—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Nalidixic Acid—Dizziness—Methotrexate—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Nalidixic Acid—Vomiting—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Nalidixic Acid—Rash—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Nalidixic Acid—Dermatitis—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Nalidixic Acid—Headache—Methotrexate—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Nalidixic Acid—Nausea—Methotrexate—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
